Close this search box.
Close this search box.


MedTech News: December 2022

Date of publication: 1 year ago

Share this:

MedTech News: December 2022

Faster and more efficient diagnostics of breast cancer with AI?


UK-based company Digistain has just passed clinical trials and opened their way to market with personalised cancer treatment recommendations. They created a cost-effective test which uses machine learning to rapidly analyse a patient’s biopsy. It has been validated in multiple hospitals in the UK and is already adopted by other institutions in India for further testing.

Why do we think it’s important? AI-based tools like this one can prove to be fast and effective and, as a result, allow for early cancer detection. This may decrease the number of patients that have to undergo potentially harmful treatments like chemotherapy. Moreover, they can be adopted in the countries where there is a shortage of specialists and further democratise high-quality healthcare all over the world!

Read more: AI breast cancer diagnostics by Digistain

Apply for Med-Tech Innovation Awards 2023!


Are you an inventor of Med-Tech products that revolutionise the industry? Now you have a chance to apply for the Med-Tech Innovation Awards in the UK and showcase your project to leading decision makers from the healthcare sector!

Submissions are free of charge and open until March 1st, 2023. There are 6 categories in which you can submit your application, i.e. 3D Printing, Connected Health, Design, Manufacturing Excellence, Materials Innovation and Sustainability.

Why do we think it’s important? Awards like this promote healthcare innovations to a broader audience and give companies the opportunity to find investors and collaborators all over the world.

Read more: Apply here


More BigTech giants invest in Brain Computer Interfaces


US-based company Synchron has been backed by Jeff Bezos and Bill Gates, together with other companies, with a 75 million USD investment round for clinical trials and further tests. The company has already implanted their interface in a human patient and showed the possibility to do it in a non-invasive way through one of the veins. They also outrun Elon Musk’s Neuralink, which is yet to test their interface on humans, planning to do that mid-2023.

Why do we think it’s important? Brain Computer Interfaces can massively increase the quality of life for people who are paralysed, allowing them to give commands to computers and smartphones. However, one of the main concerns regarding interfaces are related to privacy and security, which in our opinion needs to be addressed before releasing the technology to a larger market.

Read more: here



Who are we?

MIM Solutions is a company which gathers best-in-class Artificial Intelligence experts from Poland who revolutionise MedTech by creating fertility-improving products (MIM Fertility) and helping other companies reach their highest potential with the use of AI (MIM.AI).


Why are we sharing the news?

We believe that knowledge is power, and therefore we want you to be up to date with what is happening in MedTech. We will share such news at the end of each month to show you how MedTech is growing and how we as MIM Solutions are contributing to this growth. Stay tuned for more interesting information from the MedTech world!

Other posts

Breaking news from MIM Solutions

Follow us